- You are here:
- Home /
- For Consumers /
- Education and Prevention /
- Illicit Drugs /
Models of intervention and care for psychostimulant users, 2nd edition - monograph series no. 51
Section 2: Prevalence, effects and risks
Page last updated: April 2004
- Table of contents
- Section 1: Introduction
- Introduction
- The psychostimulant withdrawal syndrome
- The cocaine withdrawal syndrome
- The amphetamine withdrawal syndrome
- Detoxification and withdrawal management
- Assessment for detoxification
- Settings for detoxification
- Monitoring the withdrawal syndrome
- The place of pharmacotherapies
- Conclusion
- Summary of evidence
- Decision tree for the management of psychostimulant detoxification
- Introduction
- Prevalence and patterns of psychostimulant use among young people
- Risk, protection, transitions and connectedness
- Adverse effects
- Prevention and population-based interventions
- Assessment
- Management and treatment
- Treatment of young people with alcohol and other drug problems
- Specific treatment interventions
- Conclusion
- Summary of evidence
- Overview
- Prevalence of comorbid psychiatric conditions and substance use
- Psychotic disorders among psychostimulant users
- Affective and mood disorders in psychostimulant users
- Assessment of comborbidity in psychostimulant users
- Psychosocial approaches to comorbid psychiatric disorders and psychostimulant use
- Conclusion
- Chapter 12: Clinical recommendations
- Chapter 13: Future research directions
- References
- Glossary of terms
- List of abbreviations